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Joint diseases include several conditions that have great impact on society, such as 
rheumatoid arthritis or osteoarthritis. Tissue engineering is one of the most promising 
alternatives to overcome the low capacity of cartilage self-repair in those debilitating 
diseases context. 
Chitosan-polybutylene succinate (C-PBS) scaffolds have been studied for their 
suitability for cartilage tissue engineering. Previous works have shown that these 
scaffolds support chondrocytes primary cultures, its growth and ECM production. C-
PBS fiber meshes were produced by fiber extrusion, followed by hot compression, 
producing a 3D non-woven mesh of variable pore size. These fiber meshes were used 
for supporting human mesenchymal stem cells (hMSCs) chondrogenic differentiation. 
hMSCs isolated from human bone marrow were expanded until passage 2. 
Afterwards, 100.00 cells were statically seeded in each C-PBS fiber mesh, in a total of 
20. Afterwards, constructs were transferred to a flow perfusion bioreactor. Perfusion 
rate was 0,1 mL/h per scaffold. Constructs were cultured for 28 days, with 
chondrogenic differentiation medium. Differentiation was evaluated by SEM, 
histology and immunolocalisation of collagens. Preliminary results indicate that cells 
are able to proliferate and to differentiate into chondrocytes, at 14 days of culture. 
Results indicate that C-PBS fiber meshes are able to support hMSCs chondrogenic 
differentiation and extracellular matrix production. 
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